Trials / Sponsors / Celtic Pharma Development Services
Celtic Pharma Development Services
Industry · 8 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Tolerability Study of Xerecept® in Pediatric Patients Brain Edema, Brain Tumor | Phase 1 / Phase 2 | 2010-06-01 |
| Unknown | TDT 067 Onychomycosis Study Onychomycosis | Phase 3 | 2010-04-01 |
| Completed | TDT 067 Open Label Multi-Dose Onychomycosis Study Onychomycosis | Phase 2 | 2009-12-01 |
| Completed | Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers Edema | Phase 1 | 2008-12-01 |
| Completed | Study of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation Smoking | Phase 2 | 2007-05-01 |
| Withdrawn | XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema Brain Edema, Brain Tumor | Phase 3 | 2006-01-01 |
| Completed | An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated S Brain Edema, Brain Tumor | Phase 3 | 2005-07-01 |
| Completed | XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors Brain Edema, Brain Tumor | Phase 3 | 2004-05-01 |